Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James B Dale

Showing results (31-40 of 68) with videos related to

Pageof 7
Sort By:
Infection and Immunity|March 16, 2002
Immunogenicity of a 26-valent group A streptococcal vaccineMary C Hu, Michael A Walls, Steven D Stroop, et al.
Clinical and Vaccine Immunology : CVI|August 1, 2014
Group A streptococcus expresses a trio of surface proteins containing protective epitopesShannon E Niedermeyer, Thomas A Penfound, Claudia Hohn, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 3, 2021
Design of Broadly Cross-Reactive M Protein-Based Group A Streptococcal VaccinesMichelle P Aranha, Thomas A Penfound, Sanaz Salehi, et al.
Vaccine|August 14, 2024
Immunogenicity of a 30-valent M protein mRNA group A Streptococcus vaccineMeredith B Finn, Thomas A Penfound, Sanaz Salehi, et al.
Journal of the Pediatric Infectious Diseases Society|February 17, 2017
Prospective Longitudinal Analysis of Immune Responses in Pediatric Subjects After Pharyngeal Acquisition of Group A StreptococciNicholas D Hysmith, Edward L Kaplan, P Patrick Cleary, et al.
Frontiers in Cardiovascular Medicine|August 6, 2021
Utility of Human Immune Responses to GAS Antigens as a Diagnostic Indicator for ARF: A Systematic ReviewM Taariq Salie, Kimona Rampersadh, Babu Muhamed, et al.
Vaccine|February 5, 2013
Potential coverage of a multivalent M protein-based group A streptococcal vaccineJames B Dale, Thomas A Penfound, Boubou Tamboura, et al.
The Journal of Biological Chemistry|February 8, 2020
Structure-based group A streptococcal vaccine design: Helical wheel homology predicts antibody cross-reactivity among streptococcal M protein-derived peptidesMichelle P Aranha, Thomas A Penfound, Jay A Spencer, et al.
Vaccine|November 29, 2016
Structure-based design of broadly protective group a streptococcal M protein-based vaccinesJames B Dale, Pierre R Smeesters, Harry S Courtney, et al.
JAMA|August 12, 2004
Safety and immunogenicity of a recombinant multivalent group a streptococcal vaccine in healthy adults: phase 1 trialKaren L Kotloff, Mary Corretti, Kathleen Palmer, et al.
Pageof 7

Showing results (31-40 of 68) with videos related to

Sort By:
Pageof 7
Infection and Immunity|March 16, 2002
Immunogenicity of a 26-valent group A streptococcal vaccineMary C Hu, Michael A Walls, Steven D Stroop, et al.
Clinical and Vaccine Immunology : CVI|August 1, 2014
Group A streptococcus expresses a trio of surface proteins containing protective epitopesShannon E Niedermeyer, Thomas A Penfound, Claudia Hohn, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 3, 2021
Design of Broadly Cross-Reactive M Protein-Based Group A Streptococcal VaccinesMichelle P Aranha, Thomas A Penfound, Sanaz Salehi, et al.
Vaccine|August 14, 2024
Immunogenicity of a 30-valent M protein mRNA group A Streptococcus vaccineMeredith B Finn, Thomas A Penfound, Sanaz Salehi, et al.
Journal of the Pediatric Infectious Diseases Society|February 17, 2017
Prospective Longitudinal Analysis of Immune Responses in Pediatric Subjects After Pharyngeal Acquisition of Group A StreptococciNicholas D Hysmith, Edward L Kaplan, P Patrick Cleary, et al.
Frontiers in Cardiovascular Medicine|August 6, 2021
Utility of Human Immune Responses to GAS Antigens as a Diagnostic Indicator for ARF: A Systematic ReviewM Taariq Salie, Kimona Rampersadh, Babu Muhamed, et al.
Vaccine|February 5, 2013
Potential coverage of a multivalent M protein-based group A streptococcal vaccineJames B Dale, Thomas A Penfound, Boubou Tamboura, et al.
The Journal of Biological Chemistry|February 8, 2020
Structure-based group A streptococcal vaccine design: Helical wheel homology predicts antibody cross-reactivity among streptococcal M protein-derived peptidesMichelle P Aranha, Thomas A Penfound, Jay A Spencer, et al.
Vaccine|November 29, 2016
Structure-based design of broadly protective group a streptococcal M protein-based vaccinesJames B Dale, Pierre R Smeesters, Harry S Courtney, et al.
JAMA|August 12, 2004
Safety and immunogenicity of a recombinant multivalent group a streptococcal vaccine in healthy adults: phase 1 trialKaren L Kotloff, Mary Corretti, Kathleen Palmer, et al.
Pageof 7